| scholarly article | Q13442814 |
| P356 | DOI | 10.1002/CNCR.22831 |
| P698 | PubMed publication ID | 17559146 |
| P50 | author | Daniel J. Sargent | Q43055483 |
| Charles S. Fuchs | Q88762246 | ||
| Steven R Alberts | Q88846398 | ||
| Axel Grothey | Q92828335 | ||
| Stephen Williamson | Q98617101 | ||
| Henry C Pitot | Q107054204 | ||
| Roscoe F Morton | Q117264216 | ||
| Ramesh K Ramanathan | Q117264217 | ||
| Brian P Findlay | Q117264218 | ||
| P2093 | author name string | Richard M Goldberg | |
| Megan E Campbell | |||
| Amanda C Ashley | |||
| P2860 | cites work | Cancer statistics, 2006 | Q29615133 |
| Combination of oxaliplatin plus irinotecan in patients with gastrointestinal tumors: results of two independent phase I studies with pharmacokinetics | Q33330597 | ||
| Pooled analysis of safety and efficacy of oxaliplatin plus fluorouracil/leucovorin administered bimonthly in elderly patients with colorectal cancer | Q33372496 | ||
| Chemotherapy in elderly patients with colorectal cancer | Q34277764 | ||
| A randomized controlled trial of fluorouracil plus leucovorin, irinotecan, and oxaliplatin combinations in patients with previously untreated metastatic colorectal cancer. | Q34282412 | ||
| Treatment of colorectal cancer in the elderly: a review of the literature | Q36335597 | ||
| Elderly patients with fluoropyrimidine and thymidylate synthase inhibitor-resistant advanced colorectal cancer derive similar benefit without excessive toxicity when treated with irinotecan monotherapy | Q36695795 | ||
| A pooled analysis of adjuvant chemotherapy for resected colon cancer in elderly patients | Q43763447 | ||
| Combination of irinotecan (CPT-11) plus oxaliplatin (L-OHP) as first-line treatment in locally advanced or metastatic gastric cancer: a multicentre phase II trial | Q44995389 | ||
| 5-Fluorouracil-based chemotherapy for advanced colorectal cancer in elderly patients: a north central cancer treatment group study | Q45233228 | ||
| Chemotherapy permits resection of metastatic colorectal cancer: experience from Intergroup N9741. | Q45242224 | ||
| INK4/ARF germline alterations in pancreatic cancer patients. | Q54737226 | ||
| Combined irinotecan and oxaliplatin plus granulocyte colony-stimulating factor in patients with advanced fluoropyrimidine/leucovorin-pretreated colorectal cancer | Q74593436 | ||
| A multicenter, phase II trial of weekly irinotecan (CPT-11) in patients with previously treated colorectal carcinoma | Q74635392 | ||
| P433 | issue | 3 | |
| P921 | main subject | colorectal cancer | Q188874 |
| irinotecan | Q412197 | ||
| oxaliplatin | Q422327 | ||
| colorectal carcinoma | Q25493920 | ||
| metastatic colon cancer | Q108566365 | ||
| P304 | page(s) | 670-677 | |
| P577 | publication date | 2007-08-01 | |
| P1433 | published in | Cancer | Q326041 |
| P1476 | title | Updated efficacy and toxicity analysis of irinotecan and oxaliplatin (IROX) : intergroup trial N9741 in first-line treatment of metastatic colorectal cancer | |
| P478 | volume | 110 |
| Q37422341 | Adjuvant colon cancer chemotherapy: Is there an Indian standard of care? |
| Q99612013 | Amifostine protects from the peripheral sensory neuropathy induced by oxaliplatin in mice |
| Q50041173 | An Update on Randomized Clinical Trials in Metastatic Colorectal Carcinoma |
| Q33693186 | Effect of glutathione combined with cisplatin and oxaliplatin on the proliferation and apoptosis of lung carcinoma cell line |
| Q34048515 | Leveraging learning from a phase III colorectal cancer clinical trial: outcomes, methodology, meta-analysis and pharmacogenetics |
| Q34050521 | NCCTG Study N9741: leveraging learning from an NCI Cooperative Group phase III trial. |
| Q82032854 | Phase III trial of irinotecan plus infusional 5-fluorouracil/folinic acid versus irinotecan plus oxaliplatin as first-line treatment of advanced colorectal cancer |
| Q33384513 | Pilot study of irinotecan/oxalipltin (IROX) combination chemotherapy for patients with gemcitabine- and 5-fluorouracil- refractory pancreatic cancer |
| Q37118862 | Platinum neurotoxicity pharmacogenetics |
| Q27021105 | Review of systemic therapies for locally advanced and metastatic rectal cancer |
| Q37663255 | Selective use of adjuvant chemotherapy for rectal cancer patients with ypN0. |
| Q36061168 | Tegafur-uracil is a safe alternative for the treatment of colorectal cancer in patients with partial dihydropyrimidine dehydrogenase deficiency: a proof of principle. |
| Q37402459 | UGT1A1 gene polymorphism: impact on toxicity and efficacy of irinotecan-based regimens in metastatic colorectal cancer |
Search more.